Nucleic acid labeling market by Type and Application- Global Industry Analysis & Forecast to 2027

Published On : January 2021 Pages : 154 Category: Biotechnology Report Code : HC0114880

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Nucleic acid labeling market By Type (Reagents, Kits,Instruments) and Application (Oligonucleotide Labeling, In-situ Hybridization, Southern & Northern Blotting, Cellular Localization, Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Nucleic acid labeling market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Nucleic acids can be labeled at their 5´ end, 3´ end, or throughout the molecule depending on the particular application, like asto generate information on gene integrity and copy numberto diagnose specific sequences and chromosomal aberrations.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Nucleic acid labeling market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • PerkinElmer, Inc.
  • F. Hoffmann La-Roche AG
  • General Electric Healthcare Life Sciences
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • New England Biolabs
  • Enzo Biochem, Inc.
  • Vector Laboratories Inc.
  • Merck KGaA
  • Agilent Technologies

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Nucleic acid labeling market, ByType, Estimates and Forecast, 2017-2027 ($Million)

o    Reagents

o    Kits

o    Instruments

·         Nucleic acid labeling market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Oligonucleotide Labeling

o    In-situ Hybridization

o    Southern & Northern Blotting

o    Cellular Localization

o    Others

·         Nucleic acid labeling market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    PerkinElmer, Inc.

o    F. Hoffmann La-Roche AG

o    General Electric Healthcare Life Sciences

o    Thermo Fisher Scientific Inc.

o    Promega Corporation

o    New England Biolabs

o    Enzo Biochem, Inc.

o    Vector Laboratories Inc.

o    Merck KGaA

o    Agilent Technologies

·         Nucleic acid labeling market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Nucleic acid labeling market, By Country

o    U.S. Nucleic acid labeling market

o    Canada Nucleic acid labeling market

o    Mexico Nucleic acid labeling market

o    Europe

§  Europe Nucleic acid labeling market, By Country

o    UK Nucleic acid labeling market

o    Germany Nucleic acid labeling market

o    France Nucleic acid labeling market

o    Russia Nucleic acid labeling market

o    Italy Nucleic acid labeling market

o    Rest of Europe Nucleic acid labeling market

o    Asia-Pacific

§  Asia-Pacific Nucleic acid labeling market, By Country

o    China Nucleic acid labeling market

o    Japan Nucleic acid labeling market

o    South Korea Nucleic acid labeling market

o    India Nucleic acid labeling market

o    Southeast Asia Nucleic acid labeling market

o    Rest of Asia-Pacific Nucleic acid labeling market

o    South America

§  South America Nucleic acid labeling market

o    Brazil Nucleic acid labeling market

o    Argentina Nucleic acid labeling market

o    Columbia Nucleic acid labeling market

o    Rest of South America Nucleic acid labeling market

o    Middle East and Africa

§  Middle East and Africa Nucleic acid labeling market

o    Saudi Arabia Nucleic acid labeling market

o    UAE Nucleic acid labeling market

o    Egypt Nucleic acid labeling market

o    Nigeria Nucleic acid labeling market

o    South Africa Nucleic acid labeling market

o    TurkeyNucleic acid labeling market

o    Rest of MEA Nucleic acid labeling market 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Nucleic Acid Labeling  Market, By Type

5.1.     Introduction

5.2.     Global Nucleic Acid Labeling  Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Nucleic Acid Labeling  Revenue and Revenue Share by Type (2017-2021)

5.3.     Reagents

5.3.1.  Global Reagents Revenue and Growth Rate (2017-2021)

5.4.     Kits

5.4.1.  Global Kits Revenue and Growth Rate (2017-2021)

5.5.     Instruments

5.5.1.  Global Instruments Revenue and Growth Rate (2017-2021)

6.       Nucleic Acid Labeling  Market, By Applications

6.1.     Introduction

6.2.     Global Nucleic Acid Labeling  Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global Nucleic Acid Labeling  Revenue and Revenue Share by Applications (2017-2021)

6.3.     Oligonucleotide Labeling

6.3.1.  Global Oligonucleotide Labeling Revenue and Growth Rate (2017-2021)

6.4.     In-situ Hybridization

6.4.1.  Global In-situ Hybridization Revenue and Growth Rate (2017-2021)

6.5.     Southern & Northern Blotting

6.5.1.  Global Southern & Northern Blotting Revenue and Growth Rate (2017-2021)

6.6.     Cellular Localization

6.6.1.  Global Cellular Localization Revenue and Growth Rate (2017-2021)

6.7.     Others

6.7.1.  Global Others Revenue and Growth Rate (2017-2021)

7.       Nucleic Acid Labeling  Market, By Region

7.1.     Introduction

7.2.     Global Nucleic Acid Labeling  Revenue and Market Share by Regions

7.2.1.  Global Nucleic Acid Labeling  Revenue by Regions (2017-2021)

7.3.     North America Nucleic Acid Labeling  by Countries

7.3.1.  North America Nucleic Acid Labeling  Revenue and Growth Rate (2017-2021)

7.3.2.  North America Nucleic Acid Labeling  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Nucleic Acid Labeling  by Countries

7.4.1.  Europe Nucleic Acid Labeling  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Nucleic Acid Labeling  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Nucleic Acid Labeling  by Countries

7.5.1.  Asia-Pacific Nucleic Acid Labeling  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Nucleic Acid Labeling  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Nucleic Acid Labeling  by Countries

7.6.1.  South America Nucleic Acid Labeling  Revenue and Growth Rate (2017-2021)

7.6.2.  South America Nucleic Acid Labeling  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Nucleic Acid Labeling  by Countries

7.7.1.  Middle East and Africa Nucleic Acid Labeling  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Nucleic Acid Labeling  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     PerkinElmer, Inc.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     F. Hoffmann La-Roche AG

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     General Electric Healthcare Life Sciences

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Thermo Fisher Scientific Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Promega Corporation

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     New England Biolabs

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Enzo Biochem, Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Vector Laboratories Inc.

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Merck KGaA

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Agilent Technologies

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Nucleic Acid Labeling  Market Forecast (2022-2027)

9.1.     Global Nucleic Acid Labeling  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Nucleic Acid Labeling  Market Forecast by Regions (2022-2027)

9.2.1.  North America Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.1.1.  United States Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.1.2.  Canada Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.1.3.  Mexico Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.2.  Europe Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.2.1.  Germany Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.2.2.  France Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.2.3.  UK Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.2.4.  Russia Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.2.5.  Italy Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.3.1.  China Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.3.2.  Japan Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.3.3.  Korea Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.3.4.  India Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.4.  South America Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.4.1.  Brazil Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.4.2.  Argentina Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.4.3.  Columbia Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.3.  Egypt Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.4.  Nigeria Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.5.  South Africa Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.6.  Turkey Nucleic Acid Labeling  Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Nucleic Acid Labeling  Market Forecast (2022-2027)

9.3.     Nucleic Acid Labeling  Market Forecast by Type (2022-2027)

9.3.1.  Nucleic Acid Labeling  Forecast by Type (2022-2027)

9.3.2.  Nucleic Acid Labeling  Market Share Forecast by Type (2022-2027)

9.4.     Nucleic Acid Labeling  Market Forecast by Applications (2022-2027)

9.4.1.  Nucleic Acid Labeling  Forecast by Applications (2022-2027)

9.4.2.  Nucleic Acid Labeling  Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Nucleic Acid Labeling Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Nucleic Acid Labeling Revenue and Revenue Share by Type (2017-2019)
Figure Global Reagents Revenue and Growth Rate (2017-2019)
Figure Global Kits Revenue and Growth Rate (2017-2019)
Figure Global Instruments Revenue and Growth Rate (2017-2019)
Table Global Nucleic Acid Labeling Revenue and Revenue Share by Applications (2017-2019)
Figure Global Oligonucleotide Labeling Revenue and Growth Rate (2017-2019)
Figure Global In-situ Hybridization Revenue and Growth Rate (2017-2019)
Figure Global Southern & Northern Blotting Revenue and Growth Rate (2017-2019)
Figure Global Cellular Localization Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Nucleic Acid Labeling Revenue by Regions (2017-2019)
Figure North America Nucleic Acid Labeling Growth Rate (2017-2019)
Figure North America Nucleic Acid Labeling Revenue and Growth Rate (2017-2019)
Figure North America Nucleic Acid Labeling by Countries (2017-2019)
Figure North America Nucleic Acid Labeling Revenue (Million USD) by Countries (2017-2019)
Figure United States Nucleic Acid Labeling Growth Rate (2017-2019)
Figure United States Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Canada Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Mexico Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Europe Nucleic Acid Labeling Revenue and Growth Rate (2017-2019)
Figure Europe Nucleic Acid Labeling by Countries (2017-2019)
Figure Europe Nucleic Acid Labeling Revenue (Million USD) by Countries (2017-2019)
Figure Germany Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Germany Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Nucleic Acid Labeling Growth Rate (2017-2019)
Figure France Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Nucleic Acid Labeling Growth Rate (2017-2019)
Figure UK Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Russia Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Italy Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Rest of Europe Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Asia-Pacific Nucleic Acid Labeling Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Nucleic Acid Labeling by Countries (2017-2019)
Figure Asia-Pacific Nucleic Acid Labeling Revenue (Million USD) by Countries (2017-2019)
Figure China Nucleic Acid Labeling Growth Rate (2017-2019)
Figure China Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Japan Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Korea Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Nucleic Acid Labeling Growth Rate (2017-2019)
Figure India Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Southeast Asia Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Nucleic Acid Labeling Growth Rate (2017-2019)
Figure South America Nucleic Acid Labeling Revenue and Growth Rate (2017-2019)
Figure South America Nucleic Acid Labeling by Countries (2017-2019)
Figure South America Nucleic Acid Labeling Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Brazil Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Argentina Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Columbia Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Rest of South America Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Middle East and Africa Nucleic Acid Labeling Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Nucleic Acid Labeling by Countries (2017-2019)
Figure Middle East and Africa Nucleic Acid Labeling Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Saudi Arabia Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Nucleic Acid Labeling Growth Rate (2017-2019)
Figure United Arab Emirates Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Egypt Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Nigeria Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Nucleic Acid Labeling Growth Rate (2017-2019)
Figure South Africa Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Turkey Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Nucleic Acid Labeling Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2017-2019)
Table PerkinElmer, Inc. Nucleic Acid Labeling Financial Overview
Table F. Hoffmann La-Roche AG Nucleic Acid Labeling Financial Overview
Table General Electric Healthcare Life Sciences Nucleic Acid Labeling Financial Overview
Table Thermo Fisher Scientific Inc. Nucleic Acid Labeling Financial Overview
Table Promega Corporation Nucleic Acid Labeling Financial Overview
Table New England Biolabs Nucleic Acid Labeling Financial Overview
Table Enzo Biochem, Inc. Nucleic Acid Labeling Financial Overview
Table Vector Laboratories Inc. Nucleic Acid Labeling Financial Overview
Table Merck KGaA Nucleic Acid Labeling Financial Overview
Table Agilent Technologies Nucleic Acid Labeling Financial Overview
Figure Global Nucleic Acid Labeling Revenue (Millions USD) and Growth Rate (2019-2027)
Table Nucleic Acid Labeling Market Forecast by Regions (2019-2027)
Figure North America Nucleic Acid Labeling Market Forecast (2019-2027)
Figure United States Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Canada Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Mexico Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Europe Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Germany Nucleic Acid Labeling Market Forecast (2019-2027)
Figure France Nucleic Acid Labeling Market Forecast (2019-2027)
Figure UK Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Russia Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Italy Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Rest of Europe Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Asia-Pacific Nucleic Acid Labeling Market Forecast (2019-2027)
Figure China Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Japan Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Korea Nucleic Acid Labeling Market Forecast (2019-2027)
Figure India Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Southeast Asia Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Nucleic Acid Labeling Market Forecast (2019-2027)
Figure South America Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Brazil Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Argentina Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Columbia Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Rest of South America Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Middle East and Africa Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Saudi Arabia Nucleic Acid Labeling Market Forecast (2019-2027)
Figure United Arab Emirates Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Egypt Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Nigeria Nucleic Acid Labeling Market Forecast (2019-2027)
Figure South Africa Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Turkey Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Nucleic Acid Labeling Market Forecast (2019-2027)
Figure Global Nucleic Acid Labeling Forecast by Type (2019-2027)
Figure Global Nucleic Acid Labeling Market Share Forecast by Type (2019-2027)
Figure Global Nucleic Acid Labeling Forecast by Type (2019-2027)
Figure Global Nucleic Acid Labeling Forecast by Applications (2019-2027)
Figure Global Nucleic Acid Labeling Market Share Forecast by Applications (2019-2027)
Figure Global Nucleic Acid Labeling Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country